Your browser doesn't support javascript.
loading
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.
Seifert, Robert; Rasul, Sazan; Seitzer, Konstantin; Eveslage, Maria; Rahbar Nikoukar, Laya; Kessel, Katharina; Schäfers, Michael; Yu, Josef; Haug, Alexander R; Hacker, Marcus; Bögemann, Martin; Bodei, Lisa; Morris, Michael J; Hofman, Michael S; Rahbar, Kambiz.
Affiliation
  • Seifert R; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Rasul S; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Seitzer K; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Eveslage M; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Rahbar Nikoukar L; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Kessel K; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Schäfers M; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Yu J; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Haug AR; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Hacker M; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Bögemann M; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Bodei L; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Morris MJ; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Hofman MS; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
  • Rahbar K; From the Departments of Nuclear Medicine (R.S., L.R.N., K.K., M.S., K.R.) and Urology (K.S., M.B.), University Hospital Münster, Albert-Schweitzer-Campus 1, D-48149 Münster, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany (R.S.); German Cancer Consortium (DKTK), Es
Radiology ; 307(4): e222010, 2023 05.
Article in En | MEDLINE | ID: mdl-37070991

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Radiology Year: 2023 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Positron Emission Tomography Computed Tomography Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Radiology Year: 2023 Type: Article Affiliation country: Spain